British pharmaceutical company SmithKline Beecham Lrb SB Rrb said Wednesday it has stopped administering Placebos in two us trials on its heart drug because tests have shown the drug is unexpectedly "effective in reducing death rates.
Smithkline ends heart drug trial after it proved unexpectedly effective.